Prime Highlights-
- More than 300 health systems serving over 250 million patients have adopted Abridge’s technology.
- Monthly active users of the decision support tool now exceed half of eligible clinicians, with queries tripling in two months.
Key Facts-
- Abridge expands its AI decision support tool to every clinician at partner health systems.
- Health systems using the tool include Kaiser Permanente, Duke Health, UPMC and CHRISTUS Health.
Background-
Abridge, an AI healthcare technology company, has expanded its clinical decision support tool to every clinician at its partner health systems, moving beyond AI documentation to function as a broader assistant for doctors.
More than 300 enterprise health systems have adopted the tool since April, and monthly active users now make up over half of eligible clinicians, with queries per clinician tripling in the past two months.
CEO and co-founder Shiv Rao said adoption has outpaced anything the company has previously launched, noting that the tool understands patient context, draws on trusted evidence, and connects to what clinicians want to do next.
The 300 partner health systems serve more than 250 million patients, and Abridge said the tool runs on the same enterprise-approved infrastructure already used for its documentation systems, including existing security and electronic health record integrations.
Health systems using the solution include Kaiser Permanente, Sutter Health, UNC Health, CHRISTUS Health, Duke Health and UPMC.
Abridge partnered with Wolters Kluwer’s UpToDate in April to integrate clinical decision support within its documentation workflow, alongside content from The New England Journal of Medicine, JAMA Network and other medical publications.
At Duke Health, Chief Health Information Officer Eric Poon said the tool has proven helpful by quietly surfacing relevant guidance during patient visits, comparing it to having an attentive assistant anticipating his needs. About 2,000 clinicians at Duke currently use Abridge.
At UPMC, more than 60 per cent of users adopted the tool through self-discovery without formal training, according to Chief Medical Information Officer Robert Bart.
Abridge’s head of clinical strategy, Matt Troup, said the technology now supports the full clinical encounter, from pre-visit summaries to structured documentation, positioning it as a comprehensive intelligence platform for clinicians.
